Institutional HoldersBeta
Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.
Share classes (cover page of the 10-Q filed 2026-05-14, as of 2026-05-11)
| Class | Listed | Shares outstanding | Held by 13F filers | % of class | Holders | CUSIP |
|---|---|---|---|---|---|---|
| Common stock | SNYR · NASDAQ | 14,899,883 | 589,380 | 4.0% | 14 | 87165D208 |
Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.
Top holders (14 of 14 · 87165D208)
change vs 2026-03-31| # | Filer | Shares | % of class | Value | Change |
|---|---|---|---|---|---|
| 1 | JANE STREET GROUP, LLC | 181,648 | 1.22% | $36K | NEW |
| 2 | ACT Advisors, LLC. | 151,840 | 1.02% | $30K | NEW |
| 3 | XTX Topco Ltd | 61,270 | 0.41% | $12K | NEW |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 38,909 | 0.26% | $8K | -50,861 (-56.7%) |
| 5 | HRT FINANCIAL LP | 34,035 | 0.23% | $6K | NEW |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 32,775 | 0.22% | $7K | +11,377 (+53.2%) |
| 7 | Virtu Financial LLC | 18,539 | 0.12% | $4K | NEW |
| 8 | VANGUARD FIDUCIARY TRUST CO | 16,008 | 0.11% | $3K | -7,141 (-30.8%) |
| 9 | StoneX Group Inc. | 15,109 | 0.10% | $3K | NEW |
| 10 | EWA, LLC | 13,727 | 0.09% | $3K | NEW |
| 11 | CITADEL ADVISORS LLC | 10,902 | 0.07% | $2K | NEW |
| 12 | Williams & Novak, LLC | 10,020 | 0.07% | $2K | -1,925 (-16.1%) |
| 13 | Tower Research Capital LLC (TRC) | 3,714 | 0.02% | $737 | +822 (+28.4%) |
| 14 | BARCLAYS PLC | 884 | 0.01% | $175 | NEW |
Exited since 2026-03-31 (7 filers; largest 7 shown)
| HEARTLAND ADVISORS INC | −550,000 |
| GRATIA CAPITAL, LLC | −550,000 |
| SANDERS MORRIS HARRIS LLC | −415,452 |
| Warberg Asset Management LLC | −10,222 |
| UBS Group AG | −900 |
| Clearstead Advisors, LLC | −109 |
| CITIGROUP INC | −1 |
Large holders from 13D/13G (latest per reporting person, last 2 years)
Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.
| Reporting person | Form | Filed | Event | Shares | % of class |
|---|---|---|---|---|---|
| KNIGHT THERAPEUTICS INC. | SCHEDULE 13G/A | 2025-06-13 | 2025-06-11 | 1,911,414 | 19.9% |
Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.